Vijay Kotte compensation by year
GoHealth Summary Compensation Table · all 4 fiscal years held| Component | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Salary | $484,615 | $900,000 | $900,000 | $969,231 |
| Bonus | $0 | $0 | $500,000 | $2,000,000 |
| Stock awards | $5,425,820 | $3,525,000 | $2,862,187 | $10,734,997 |
| Option awards | $1,614,992 | $691,664 | $664,164 | $0 |
| Non-equity incentive | $1,670,400 | $0 | $1,305,000 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $10,572 | $25,210 | $31,421 | $53,027 |
| Total | $9,206,399 | $5,141,874 | $6,262,772 | $13,757,255 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GoHealth, Inc. DEF 14A filed April 30, 2026, accession 0001140361-26-018208, and prior-year filings. Open the filing on EDGAR.
How this page was built: the GoHealth, Inc. filed document, accession 0001140361-26-018208. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 218,551 | $469,885 | — |
| RSU | 185,000 | $397,750 | — |
| RSU | 111,112 | $238,891 | — |
| RSU | 55,556 | $119,445 | — |
| Option | 47,222 | — | $11.85 |
| Option | 55,556 | — | $10.65 |
| Option | 27,778 | — | $14.10 |
Per the Outstanding Equity Awards at Fiscal Year-End table in GoHealth, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
4 Form 4 lines since the FY2025 proxy (filed April 30, 2026)current to 2026-11-06 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-07-21 | Disposition to the issuer derivative | — | 83,333 | $0.00 | 0 |
| 2026-07-21 | Disposition to the issuer derivative | — | 83,333 | $0.00 | 0 |
| 2026-07-21 | Disposition to the issuer | — | 1,347,396 | — | 0 |
| 2026-07-21 | Disposition to the issuer derivative | — | 188,888 | $0.00 | 0 |
The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments GoHealth discloses, by trigger · FY2025| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Resignation for good reason, no change in control | $2,000,000 | — | — | — |
| Involuntary termination without cause | $2,000,000 | — | — | — |
| Death | $2,000,000 | — | — | — |
Per the Potential Payments Upon Termination or Change in Control table in GoHealth, Inc.'s FY2025 proxy. Estimates as the company printed them; a dash means it printed no figure.
GoHealth’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Vijay Kotte · this page | Chief Executive Officer | $13,757,255 |
| Michael Hargis | Chief Operating Officer | $2,192,562 |
| Brendan Shanahan | Chief Financial Officer | $2,058,938 |
Board service
GoHealth board · FY2023–FY2025How this board is paid
Company policy: GoHealth pays directors a $150,000 cash retainer and $150,000 in equity. As stated in GoHealth's FY2025 proxy.
The full GoHealth compensation record
free company briefThis page is one person within GoHealth's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order GoHealth's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GoHealth's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order GOCO
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.